Old Mission Capital’s BeOne Medicines Ltd ONC Stock Holding History

Old Mission Capital’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.67M	Buy	+5,846	New	+$1.72M	0.03%	323
2025 Q2	–	Sell	-29,278	Closed	-$7.97M	–	1416
2025 Q1	$7.97M	Buy	+29,278	New	+$6.84M	0.11%	83
2024 Q4	–	Sell	-58,467	Closed	-$13.1M	–	1268
2024 Q3	$13.1M	Buy	+58,467	New	+$10.5M	0.19%	99
2023 Q1	–	Sell	-26,222	Closed	-$5.77M	–	1756
2022 Q4	$5.77M	Buy	+26,222	New	+$4.81M	0.16%	131
2022 Q3	–	Sell	-68,336	Closed	-$11.1M	–	1406
2022 Q2	$11.1M	Buy	68,336 +36,602	+115%	+$5.72M	0.31%	53
2022 Q1	$5.99M	Buy	+31,734	New	+$6.75M	0.17%	91
2021 Q3	–	Sell	-14,597	Closed	-$5.01M	–	1308
2021 Q2	$5.01M	Buy	14,597 +8,399	+136%	+$2.78M	0.17%	109
2021 Q1	$2.16M	Sell	6,198 -836	-12%	-$277K	0.12%	207
2020 Q4	$1.82M	Buy	+7,034	New	+$1.94M	0.11%	164

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Old Mission Capital's ONC Position: Q2 2026 in Review

Old Mission Capital opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 5,846 shares worth $1.67M. The stake represents 0.03% of the portfolio and ranks #323 among its holdings. This is a return to the name: Old Mission Capital previously reported a position in ONC as recently as Q1 2025.

Old Mission Capital first reported a position in ONC in Q4 2020 and has held it in 9 quarters since. The position peaked at $13.1M in Q3 2024. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Old Mission Capital held 5,846 shares of BeOne Medicines Ltd worth $1.67M as of Q2 2026.
BeOne Medicines Ltd was a new Old Mission Capital position in Q2 2026.
BeOne Medicines Ltd made up 0.03% of Old Mission Capital's portfolio in Q2 2026, its #323 holding.
Old Mission Capital first reported a position in BeOne Medicines Ltd in Q4 2020 and has held it in 9 quarters since.
Old Mission Capital's BeOne Medicines Ltd position peaked at $13.1M in Q3 2024.
283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Old Mission Capital's 13F filing for Q2 2026, filed 14 Aug 2026.